{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:47:42Z","timestamp":1789015662298,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["JRF"],"award-info":[{"award-number":["JRF"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["GAP0138"],"award-info":[{"award-number":["GAP0138"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0925-3","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T12:13:08Z","timestamp":1501762388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["microRNA dysregulation in polyglutamine toxicity of TATA-box\u00a0binding protein is mediated through STAT1 in mouse neuronal cells"],"prefix":"10.1186","volume":"14","author":[{"given":"Reema","family":"Roshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksheev","family":"Bhambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawani","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanay","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"issue":"9","key":"925_CR1","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1074\/jbc.M109.036335","volume":"285","author":"P Breuer","year":"2010","unstructured":"Breuer P, et al. Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control. J Biol Chem. 2010;285(9):6532\u20137.","journal-title":"J Biol Chem"},{"key":"925_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-6606-2-21","volume":"2","author":"LS Havel","year":"2009","unstructured":"Havel LS, Li S, Li XJ. Nuclear accumulation of polyglutamine disease proteins and neuropathology. Mol Brain. 2009;2:21.","journal-title":"Mol Brain"},{"issue":"12","key":"925_CR3","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.56.12.1753","volume":"56","author":"K Ishikawa","year":"2001","unstructured":"Ishikawa K, et al. Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology. 2001;56(12):1753\u20136.","journal-title":"Neurology"},{"key":"925_CR4","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1093\/hmg\/ddg295","volume":"12 Spec No 2","author":"A Michalik","year":"2003","unstructured":"Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet. 2003;12 Spec No 2:R173\u201386.","journal-title":"Hum Mol Genet"},{"issue":"9557","key":"925_CR5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington's disease. Lancet. 2007;369(9557):218\u201328.","journal-title":"Lancet"},{"key":"925_CR6","unstructured":"Toyoshima Y, et al. Spinocerebellar Ataxia Type 17. In: Pagon RA, et al, editors. GeneReviews(R). Seattle (WA): University of Washington; 1993. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1438\/ ."},{"issue":"4","key":"925_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang CC, et al. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet. 1998;24(4):217\u201333.","journal-title":"Somat Cell Mol Genet"},{"issue":"2","key":"925_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004010100364","volume":"102","author":"T Uchihara","year":"2001","unstructured":"Uchihara T, et al. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias\u2014triple-labeling immunofluorescence study. Acta Neuropathol. 2001;102(2):149\u201352.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"925_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molbrainres.2004.03.018","volume":"125","author":"SJ Reid","year":"2004","unstructured":"Reid SJ, et al. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer\u2019s disease. Brain Res Mol Brain Res. 2004;125(1\u20132):120\u20138.","journal-title":"Brain Res Mol Brain Res"},{"issue":"4","key":"925_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jnen\/60.4.369","volume":"60","author":"J Takahashi","year":"2001","unstructured":"Takahashi J, et al. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol. 2001;60(4):369\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17","key":"925_CR11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, et al. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington\u2019s disease mouse models reveal context-independent effects. Hum Mol Genet. 2002;11(17):1927\u201337.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"925_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001170","volume":"2","author":"T Ghosh","year":"2007","unstructured":"Ghosh T, et al. A role for voltage-dependent anion channel Vdac1 in polyglutamine-mediated neuronal cell death. PLoS One. 2007;2(11):e1170.","journal-title":"PLoS One"},{"issue":"6","key":"925_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4161\/rna.19876","volume":"9","author":"R Roshan","year":"2012","unstructured":"Roshan R, et al. Regulation of BACE1 by miR-29a\/b in a cellular model of Spinocerebellar Ataxia 17. RNA Biol. 2012;9(6):891\u20139.","journal-title":"RNA Biol"},{"issue":"8","key":"925_CR14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1261\/rna.044008.113","volume":"20","author":"R Roshan","year":"2014","unstructured":"Roshan R, et al. Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice. RNA. 2014;20(8):1287\u201397.","journal-title":"RNA"},{"key":"925_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nbd.2014.10.006","volume":"73","author":"AS Papadopoulou","year":"2015","unstructured":"Papadopoulou AS, et al. Deficiency of the miR-29a\/b-1 cluster leads to ataxic features and cerebellar alterations in mice. Neurobiol Dis. 2015;73:275\u201388.","journal-title":"Neurobiol Dis"},{"issue":"23\u201324","key":"925_CR16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.drudis.2009.09.009","volume":"14","author":"R Roshan","year":"2009","unstructured":"Roshan R, et al. MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today. 2009;14(23\u201324):1123\u20139.","journal-title":"Drug Discov Today"},{"issue":"2","key":"925_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1101\/gad.1975411","volume":"25","author":"AJ Kole","year":"2011","unstructured":"Kole AJ, et al. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 2011;25(2):125\u201330.","journal-title":"Genes Dev"},{"issue":"D1","key":"925_CR18","doi-asserted-by":"crossref","first-page":"D726","DOI":"10.1093\/nar\/gkv1160","volume":"44","author":"CA Sloan","year":"2016","unstructured":"Sloan CA, et al. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44(D1):D726\u201332.","journal-title":"Nucleic Acids Res"},{"issue":"7414","key":"925_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374.","journal-title":"Nature"},{"issue":"4","key":"925_CR20","first-page":"373","volume":"13","author":"RJ Goody","year":"2007","unstructured":"Goody RJ, et al. JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neuro-Oncol. 2007;13(4):373\u201383.","journal-title":"J Neuro-Oncol"},{"issue":"12","key":"925_CR21","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s11064-011-0547-6","volume":"36","author":"K Osuka","year":"2011","unstructured":"Osuka K, et al. Activation of STAT1 in neurons following spinal cord injury in mice. Neurochem Res. 2011;36(12):2236\u201343.","journal-title":"Neurochem Res"},{"issue":"11","key":"925_CR22","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.WCB.0000034148.72481.F4","volume":"22","author":"Y Takagi","year":"2002","unstructured":"Takagi Y, et al. STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab. 2002;22(11):1311\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"17","key":"925_CR23","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, et al. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105(17):6415\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"925_CR24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, et al. A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis. 2008;29(3):438\u201345.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"925_CR25","volume":"2","author":"N Au-Yeung","year":"2013","unstructured":"Au-Yeung N, Mandhana R, Horvath CM. Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAKSTAT. 2013;2(3):e23931.","journal-title":"JAKSTAT"},{"key":"925_CR26","doi-asserted-by":"crossref","unstructured":"Ramana, CV, et al. Complex roles of Stat1 in regulating gene expression. Oncogene. 2000;19(21):2619\u201327.","DOI":"10.1038\/sj.onc.1203525"},{"issue":"4","key":"925_CR27","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4049\/jimmunol.1103171","volume":"189","author":"KM Smith","year":"2012","unstructured":"Smith KM, et al. miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol. 2012;189(4):1567\u201376.","journal-title":"J Immunol"},{"issue":"2","key":"925_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.immuni.2011.07.009","volume":"35","author":"DF Steiner","year":"2011","unstructured":"Steiner DF, et al. MicroRNA-29 regulates T-box transcription factors and interferon-gamma production in helper T cells. Immunity. 2011;35(2):169\u201381.","journal-title":"Immunity"},{"issue":"20","key":"925_CR29","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.0602460103","volume":"103","author":"S Delhaye","year":"2006","unstructured":"Delhaye S, et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A. 2006;103(20):7835\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"925_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1073\/pnas.97.1.91","volume":"97","author":"C Contursi","year":"2000","unstructured":"Contursi C, et al. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci U S A. 2000;97(1):91\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5164","key":"925_CR31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264(5164):1415\u201321.","journal-title":"Science"},{"issue":"1\u20132","key":"925_CR32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0165-5728(02)00050-4","volume":"126","author":"N Abbas","year":"2002","unstructured":"Abbas N, et al. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol. 2002;126(1\u20132):50\u20137.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"925_CR33","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1096\/fj.08-105866","volume":"22","author":"R Baron","year":"2008","unstructured":"Baron R, et al. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer\u2019s disease. FASEB J. 2008;22(8):2843\u201352.","journal-title":"FASEB J"},{"issue":"5","key":"925_CR34","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2353\/ajpath.2009.090059","volume":"175","author":"MA Mastrangelo","year":"2009","unstructured":"Mastrangelo MA, et al. Interferon-{gamma} differentially affects Alzheimer\u2019s disease pathologies and induces neurogenesis in triple transgenic-AD mice. Am J Pathol. 2009;175(5):2076\u201388.","journal-title":"Am J Pathol"},{"issue":"5","key":"925_CR35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","volume":"35","author":"JM Taylor","year":"2014","unstructured":"Taylor JM, et al. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(5):1012\u201323.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"925_CR36","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1007\/s12035-015-9156-8","volume":"53","author":"M Muller","year":"2016","unstructured":"Muller M, et al. MicroRNA-29a is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid. Mol Neurobiol. 2016;53(5):2894\u20139.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"925_CR37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/14712598.7.4.535","volume":"7","author":"M Clerico","year":"2007","unstructured":"Clerico M, Contessa G, Durelli L. Interferon-beta1a for the treatment of multiple sclerosis. Expert Opin Biol Ther. 2007;7(4):535\u201342.","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"925_CR38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/14712598.8.9.1435","volume":"8","author":"B Weinstock-Guttman","year":"2008","unstructured":"Weinstock-Guttman B, Ramanathan M, Zivadinov R. Interferon-beta treatment for relapsing multiple sclerosis. Expert Opin Biol Ther. 2008;8(9):1435\u201347.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"925_CR39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CDLI.8.3.628-631.2001","volume":"8","author":"SA Ghanekar","year":"2001","unstructured":"Ghanekar SA, et al. Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin Diagn Lab Immunol. 2001;8(3):628\u201331.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"925_CR40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87(5):779\u201389.","journal-title":"J Leukoc Biol"},{"key":"925_CR41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fneur.2013.00030","volume":"4","author":"DG Hernandez-Ontiveros","year":"2013","unstructured":"Hernandez-Ontiveros DG, et al. Microglia activation as a biomarker for traumatic brain injury. Front Neurol. 2013;4:30.","journal-title":"Front Neurol"},{"issue":"2","key":"925_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00401-014-1317-8","volume":"128","author":"M Bsibsi","year":"2014","unstructured":"Bsibsi M, et al. Demyelination during multiple sclerosis is associated with combined activation of microglia\/macrophages by IFN-gamma and alpha B-crystallin. Acta Neuropathol. 2014;128(2):215\u201329.","journal-title":"Acta Neuropathol"},{"issue":"7612","key":"925_CR43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano AJ, et al. Unexpected role of interferon-gamma in regulating neuronal connectivity and social behaviour. Nature. 2016;535(7612):425\u20139.","journal-title":"Nature"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0925-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T04:20:42Z","timestamp":1602649242000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0925-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0925-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]},"article-number":"155"}}